$48.00+1.81 (+3.92%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
Prestige Consumer Healthcare (PBH) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 4.3% in FY26, net margin 17.5%, and free cash flow (~$246.4M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY22–FY26
Revenue ($M)▼4.3%
1,088.7
FY22→FY26CAGR +0.0%/yr
Net income ($M)▼11.3%
190.3
one-off year: see footnoteCAGR −1.9%/yr
Free cash flow ($M)▲1.3%
246.4
FY22→FY26CAGR −0.4%/yr
Diluted EPS▼8.9%
3.91
buyback-liftedCAGR −0.8%/yr
What the receipts whisper · what a headline number hides
Share count
−4.2%
50.8mn → 48.7mn diluted shares since FY22. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$11.2M
+35.9% YoY in FY26 · 1.0% of revenue.
What the income statement says · FY22–FY26
Where every revenue dollar goes · FY26 ($M)
17¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 57.1% → 54.7%. Net margin 17.5% is more than double the sector median.
The receipt · income statement · FY22–FY26 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY26 | FY25 | FY24 | FY23 | FY22 | YoY | CAGR 22→26 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 1,167.1 | 1,088.7 | 1,137.8 | 1,125.4 | 1,127.7 | 1,086.8 | ▼4.3% | +0.0% |
Cost of revenue | 554.7 | 493.1 | 503.3 | 500.9 | 502.4 | 466.2 | ▼2.0% | +1.4% |
Gross profit | 612.4 | 595.6 | 634.5 | 624.4 | 625.3 | 620.6 | ▼6.1% | −1.0% |
Selling, general & admin | 134.2 | 116.4 | 108.2 | 106.2 | 107.4 | 107.5 | ▲7.6% | +2.0% |
Total operating expenses | 321.2 | 286.2 | 297.7 | 282.0 | 647.7 | 290.7 | ▼3.9% | −0.4% |
Operating incomefeeds ROC rank | 291.2 | 309.4 | 336.8 | 342.4 | −22.4 | 329.9 | ▼8.1% | −1.6% |
Other income, net | −78.6 | −51.9 | −52.6 | −66.4 | −71.5 | −67.5 | — | — |
Pretax income | 212.6 | 257.5 | 284.2 | 276.0 | −93.9 | 262.5 | ▼9.4% | −0.5% |
Income tax | 57.5 | 67.2 | 69.6 | 66.7 | −11.6 | 57.1 | ▼3.4% | +4.2% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 155.1 | 190.3 | 214.6 | 209.3 | −82.3 | 205.4 | ▼11.3% | −1.9% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 3.24 | 3.91 | 4.29 | 4.17 | −1.65 | 4.04 | ▼8.9% | −0.8% |
Diluted shares (mn) | 47.59 | 48.72 | 50.08 | 50.18 | 49.89 | 50.84 | ▼2.7% | −1.1% |
| Margins | ||||||||
Gross margin30th pct in Healthcare | 52.5% | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% | ▼1.1pp | −2.4pp |
Operating margin | 25.0% | 28.4% | 29.6% | 30.4% | −2.0% | 30.4% | ▼1.2pp | −1.9pp |
Net margin74th pct in Healthcare | 13.3% | 17.5% | 18.9% | 18.6% | −7.3% | 18.9% | ▼1.4pp | −1.4pp |
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 12% vs a 24% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-05-14 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Prestige Consumer Healthcare's revenue last fiscal year?
Prestige Consumer Healthcare reported revenue of $1,088.7M in fiscal 2026, down 4.3% from fiscal 2025.
What was Prestige Consumer Healthcare's net income?
Prestige Consumer Healthcare reported net income of $190.3M in fiscal 2026, a net margin of 17.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

